< Back to previous page
Organisation
Department of Pharmaceutics
Department
Main organisation:Faculty of Pharmaceutical Sciences
Lifecycle:1 Jan 1993 → Today
Organisation profile:The department consists of four departments: laboratory of pharmaceutical technology, laboratory of general biochemistry and physical pharmacy, laboratory of pharmaceutical biotechnology, laboratory of medicinal chemistry
Keywords:Geneesmiddelenleer
Disciplines:Medicinal products, Drug discovery and development
Current researchers
1 - 10 of 170 results
- Justine Aelvoet (Member)
- Ilke Aernout (Member)
- Amin Ahmad (Member)
- Mohsin Ali (Member)
- Ruben Almey (Member)
- Léo Baland (Member)
- Margaux Bauwens (Member)
- Dominika Berdecka (Member)
- Danique Berrevoet (Member)
Projects
1 - 10 of 470
- Advancing NANOmedicines to rewire tumoral MYeloid cells for next-generation cancer immunotherapiesFrom1 May 2026 → TodayFunding: HORIZON.1.1 - European Research Council (ERC)
- Belgian representation in the Scientific Advice Working Party (SAWP) of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) - 2026-2029From1 Mar 2026 → TodayFunding: FOD Public Health, Safety of the food chain and the Environment
- High-Precision Mapping of HLA Gene Links to Clozapine-Induced Neutropenia via Long-Read Amplicon Sequencing with Double UMIsFrom1 Mar 2026 → TodayFunding: BOF - doctoral mandates
- Multiparameter particle-to-particle analysis of lipid nanoparticles to correlate particle heterogeneity with biological activityFrom1 Jan 2026 → TodayFunding: FWO research project (including WEAVE projects)
- Nanomedicines: leveraging nucleic acid therapeuticsFrom1 Jan 2026 → TodayFunding: FWO scientific research network
- Overcoming systemic toxicity of IL-12 cancer immunotherapy through conditional activation of cell surface–anchored IL-12 in the tumor microenvironment.From1 Jan 2026 → TodayFunding: FWO research project (including WEAVE projects)
- Gene editing of CAR-T cells with innovative lipid nanoparticle designs and transfection performance enhancersFrom1 Jan 2026 → TodayFunding: FWO research project (including WEAVE projects)
- Predicting optimal process conditions for the production of highly drug-loaded pelletsFrom1 Jan 2026 → TodayFunding: BOF - projects
- ABscope: scalable specificity profiling for biotherapeuticsFrom31 Dec 2025 → TodayFunding: IOF - technology validation in lab
- Image analysis platform for users of the GLiM core facilityFrom1 Dec 2025 → TodayFunding: BOF - scientific equipment program
Publications
1 - 10 of 2706
- Development of a self-replicating mRNA vaccine against Zika virus(2020)
- Dupilumab effect on asthma control and health-related quality of life in patients with oral corticosteroid-dependent severe asthma with comorbid chronic rhinosinusitis with and without nasal polyps(2019)Volume: 74Pages: 27 - 27
- Inhaled anticholinergic drugs and risk of acute urinary retention(2008)Volume: 17Pages: 054
- Chronic use of oral corticosteroids in severe asthmatics in the Belgian Severe Asthma Registry (BSAR)(2019)Volume: 199Number of pages: 1
- Best-in-class PCR based target enrichment for NGS panels and Sanger variant confirmation(2015)Number of pages: 1
- The inflammasome pathway is involved in PXE through IL1B upregulation in patients with a severe cardiovascular PXE phenotype(2019)Volume: 27Pages: 124 - 125
- I C no O : C-glycosides of promising C6”-modified α-GalCer analogues(2016)Number of pages: 1
- Efficient delivery of intact phosphodiester oligonucleotides by poly-β-amino esters(2010)Published in: JOURNAL OF CONTROLLED RELEASEISSN: 0168-3659Issue: 1Volume: 144Pages: 65 - 74
- Serotonin reuptake inhibitors selectively decrease proliferation and viability of activated T-cells(2011)Volume: 135Pages: 183 - 183
- Cigarette smoking and inflammatory bowel disease : insights into microbial and immune homeostasis(2016)Pages: 247 p.